Cementos Bio-Bio (XSGO:CEMENTOS) ROE %: 19.17% (As of Dec. 2025) — 113% Above Median


XSGO:CEMENTOS Cementos Bio-Bio SA XSGO:CEMENTOS
32 GF Score
Price CLP1,730.00
GF Value CLP740.61
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Cementos Bio-Bio ROE %?

Cementos Bio-Bio XSGO:CEMENTOS 32 ROE % is 19.17% as of Dec. 2025, which is 113% above its 10-year median of 8.98. GuruFocus rates XSGO:CEMENTOS with a GF Score™ of 32/100 and a GF Value™ of CLP740.61 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 402 Building Materials companies, Cementos Bio-Bio ranks better than 78.11% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Cementos Bio-Bio's annualized net income for the quarter that ended in Dec. 2025 was CLP55,133 Mil. Cementos Bio-Bio's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was CLP287,651 Mil. Therefore, Cementos Bio-Bio's annualized ROE % for the quarter that ended in Dec. 2025 was 19.17%.

The historical rank and industry rank for Cementos Bio-Bio's ROE % or its related term are showing as below:

XSGO:CEMENTOS' s ROE % Range Over the Past 10 Years
Min: 4.24   Med: 8.98   Max: 12.34
Current: 11.81

During the past 13 years, Cementos Bio-Bio's highest ROE % was 12.34%. The lowest was 4.24%. And the median was 8.98%.

XSGO:CEMENTOS's ROE % is ranked better than
78.11% of 402 companies
in the Building Materials industry
Industry Median: 4.335 vs XSGO:CEMENTOS: 11.81

Cementos Bio-Bio  (XSGO:CEMENTOS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=55132.588/287650.7955
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(55132.588 / 386106.668)*(386106.668 / 521671.2095)*(521671.2095 / 287650.7955)
=Net Margin %*Asset Turnover*Equity Multiplier
=14.28 %*0.7401*1.8136
=ROA %*Equity Multiplier
=10.57 %*1.8136
=19.17 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=55132.588/287650.7955
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (55132.588 / 59737.856) * (59737.856 / 58394.504) * (58394.504 / 386106.668) * (386106.668 / 521671.2095) * (521671.2095 / 287650.7955)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9229 * 1.023 * 15.12 % * 0.7401 * 1.8136
=19.17 %

Note: The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Cementos Bio-Bio ROE % Related Terms


Cementos Bio-Bio ROE % Historical Data

* Premium members only.

The historical data trend for Cementos Bio-Bio's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cementos Bio-Bio ROE % Chart

Cementos Bio-Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.77 4.24 9.18 12.34 11.85

Cementos Bio-Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.78 8.67 9.03 10.05 19.17

XSGO:CEMENTOS vs CRH, VMC, MLM: ROE % Comparison

For the Building Materials subindustry, Cementos Bio-Bio's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cementos Bio-Bio ROE % vs Building Materials Industry

For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's ROE % distribution charts can be found below:

* The bar in red indicates where Cementos Bio-Bio's ROE % falls into.


XSGO:CEMENTOS
32GF Score
Cementos Bio-Bio SA XSGO:CEMENTOS
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cementos Bio-Bio ROE % Calculation

Cementos Bio-Bio's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=33087.78/( (270071.331+288150.098)/ 2 )
=33087.78/279110.7145
=11.85 %

Cementos Bio-Bio's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=55132.588/( (287151.493+288150.098)/ 2 )
=55132.588/287650.7955
=19.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 19.17% mean?
Cementos Bio-Bio (XSGO:CEMENTOS) has a ROE % of 19.17% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Cementos Bio-Bio and its competitors. This is 113% above median its historical median of 8.98. Over the past decade, Cementos Bio-Bio's ROE % has ranged from 4.24 to 12.34. According to the industry distribution chart, Cementos Bio-Bio ranks #88 out of 402 companies in the Building Materials industry, placing it in the top 21.9%.
Is Cementos Bio-Bio's ROE % too high?
Cementos Bio-Bio's current ROE % of 19.17% is 113% above median its 10-year median of 8.98. Over the past 10 years, this metric has ranged from a low of 4.24 to a high of 12.34. The Building Materials industry median ROE % is 4.34. Cementos Bio-Bio's value of 19.17% is 342.2% above this industry median. Based on the distribution chart, Cementos Bio-Bio ranks #88 out of 402 companies in the Building Materials industry, which is in the top quartile — a strong position relative to peers. Overall, Cementos Bio-Bio has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's ROE % compare to CRH and VMC?
According to the Building Materials industry distribution chart, Cementos Bio-Bio ranks #88 out of 402 companies for ROE %. This places Cementos Bio-Bio in the top 22% of its industry — outperforming the majority of peers. The industry median ROE % is 4.34. Cementos Bio-Bio's value of 19.17% is 342.2% above this benchmark. Historically, Cementos Bio-Bio's own ROE % has ranged from 4.24 to 12.34 over the past decade. While the company's 10-year median is 8.98 vs. the industry median of 4.34, Cementos Bio-Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Building Materials company?
The median ROE % among Building Materials companies is 4.34, based on 402 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cementos Bio-Bio's current ROE % of 19.17% is 342.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Cementos Bio-Bio and its competitors. For the Building Materials industry, the median ROE % is 4.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cementos Bio-Bio's current ROE % is 19.17%, which is 113% above median its own 10-year median of 8.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Based on GuruFocus' analysis, Cementos Bio-Bio (XSGO:CEMENTOS) is currently considered Significantly Overvalued. The stock's GF Value™ is CLP740.61, compared to a current price of CLP1,730.00 — trading 133.6% above its estimated fair value. The current ROE % is 19.17%, which is 113% above median its 10-year median of 8.98 and 342.2% above the Building Materials industry median of 4.34. Cementos Bio-Bio's overall GF Score™ is 32/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current ROE % is 19.17% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?

Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued. The current stock price of CLP1,730.00 is trading 133.6% above its estimated GF Value™ of CLP740.61. GuruFocus considers Cementos Bio-Bio to be Significantly Overvalued.

Key valuation signals for XSGO:CEMENTOS:

  • ROE %: 19.17% (113% above median its 10-year median of 8.98)
  • GF Value™: CLP740.61 vs. price of CLP1,730.00 (133.6% above fair value)
  • GF Score™: 32/100 with 8 warning signs
  • Industry Position: 342.2% above the Building Materials median (#88 of 402)

No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cementos Bio-Bio Business Description

Address Barros Errazuriz No.1968, Piso 6, Santiago, CHL
Cementos Bio-Bio SA is a cement manufacturing company. The company manufactures and distributes construction materials.
32GF Score

Get the complete analysis for XSGO:CEMENTOS

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CLP1,730.00
Price
CLP740.61
GF Value